Induction of sustained patency after clot-selective coronary thrombolysis with Hybrid-B, a genetically engineered plasminogen activator with a prolonged biological half-life.
Carla J. Weinheimer(University of Washington), Steven R. Bergmann(Washington University in St. Louis), Narender K. Kalyan(Washington University in St. Louis), P.P. Hung(Washington University in St. Louis), Burton E. Sobel, S G Lee(Washington University in St. Louis), Harold L. James, J Wilhelm(Washington University in St. Louis)
Cited by 12
Related Papers
Circadian Variation in the Frequency of Onset of Acute Myocardial Infarction
|New England Journal of Medicine|1985|1.9k
Itaconate Links Inhibition of Succinate Dehydrogenase with Macrophage Metabolic Remodeling and Regulation of Inflammation
|Cell Metabolism|2016|1.5k
A critical role for the peroxisome proliferator-activated receptor α (PPARα) in the cellular fasting response: The PPARα-null mouse as a model of fatty acid oxidation disorders
|Proceedings of the National Academy of Sciences|1999|940
Tissue Resident CCR2− and CCR2+ Cardiac Macrophages Differentially Orchestrate Monocyte Recruitment and Fate Specification Following Myocardial Injury
|Circulation Research|2019|717
Akt1 Is Required for Physiological Cardiac Growth
|Circulation|2006|529